Production of endothelin-1 and thrombomodulin by human pancreatic cancer cells
1994

Endothelin-1 and Thrombomodulin Production in Pancreatic Cancer Cells

Sample size: 12 publication Evidence: moderate

Author Information

Author(s): T. Oikawa, M. Kusuhara, S. Ishikawa, J. Hitomi, A. Kono, T. Iwanaga, K. Yamaguchi

Primary Institution: National Cancer Center Research Institute

Hypothesis

Do pancreatic cancer cells produce endothelin-1 and thrombomodulin similar to vascular endothelial cells?

Conclusion

Pancreatic cancer cells frequently produce endothelin-1 and thrombomodulin, suggesting they share characteristics with vascular endothelial cells.

Supporting Evidence

  • Endothelin-1 was detected in 11 of 12 pancreatic cancer cell lines (92%).
  • Thrombomodulin was detected in 11 of the 12 cell lines (92%) and released into the culture medium in 58% of these cell lines.
  • TM mRNA was detected in the pancreatic cancer cells, indicating active production.

Takeaway

This study found that pancreatic cancer cells make two important substances, endothelin-1 and thrombomodulin, which are usually made by blood vessel cells.

Methodology

The study involved analyzing 12 human pancreatic cancer cell lines for the production of endothelin-1 and thrombomodulin using radioimmunoassays and enzyme immunoassays.

Limitations

The study was limited to a small number of pancreatic cancer cell lines and did not explore the clinical implications in patients.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication